Education
About Us
Working with TipRanks
Follow Us
American Bio Medica Corporation (ABMC)
:ABMC
Total Valuation
American Bio Medica has a market cap or net worth of $4.81K. The enterprise value is $2.47M.
Market Cap$4.81K
Enterprise Value$2.47M
Share Statistics
American Bio Medica has 48,098,476 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding48,098,476
Owned by Insiders―
Owned by Institutions0.09%
Financial Efficiency
American Bio Medica’s return on equity (ROE) is 0.60 and return on invested capital (ROIC) is 1256.33%.
Return on Equity (ROE)0.60
Return on Assets (ROA)-1.11
Return on Invested Capital (ROIC)1256.33%
Return on Capital Employed (ROCE)0.53
Revenue Per Employee57.06K
Profits Per Employee-88.13K
Employee Count16
Asset Turnover0.72
Inventory Turnover2.92
Valuation Ratios
The current PE Ratio of American Bio Medica is -0.19. American Bio Medica’s PEG ratio is >-0.01.
PE Ratio-0.19
PS Ratio0.00
PB Ratio-0.11
Price to Fair Value-0.11
Price to FCF-0.34
Price to Operating Cash Flow-0.34
PEG Ratio>-0.01
Income Statement
In the last 12 months, American Bio Medica had revenue of 913.00K and earned -1.41M in profits. Earnings per share was -0.03.
Revenue913.00K
Gross Profit-193.00K
Operating Income-1.24M
Pretax Income-1.41M
Net Income-1.41M
EBITDA-1.16M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -974.00K and capital expenditures 0.00, giving a free cash flow of -974.00K billion.
Operating Cash Flow-974.00K
Free Cash Flow-974.00K
Free Cash Flow per Share-0.02
Dividends & Yields
American Bio Medica pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta190.61
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
American Bio Medica upcoming earnings date is Nov 17, 2022, TBA Not Confirmed.
Last Earnings DateAug 15, 2022
Next Earnings DateNov 17, 2022
Ex-Dividend Date―
Financial Position
American Bio Medica as a current ratio of 0.21, with Debt / Equity ratio of -95.77%
Current Ratio0.21
Quick Ratio0.11
Debt to Market Cap8.44
Net Debt to EBITDA-1.90
Interest Coverage Ratio-6.40
Taxes
In the past 12 months, American Bio Medica has paid 2.00K in taxes.
Income Tax2.00K
Effective Tax Rate>-0.01
Enterprise Valuation
American Bio Medica EV to EBITDA ratio is -2.12, with an EV/FCF ratio of -3.22.
EV to Sales2.71
EV to EBITDA-2.12
EV to Free Cash Flow-3.22
EV to Operating Cash Flow-3.22
Balance Sheet
American Bio Medica has $0.00 in cash and marketable securities with $0.00 in debt, giving a net cash position of $0.00 billion.
Cash & Marketable Securities$0.00
Total Debt$0.00
Net Cash$0.00
Net Cash Per Share$0.00
Tangible Book Value Per Share-$0.05
Margins
Gross margin is -21.14%, with operating margin of -136.04%, and net profit margin of -154.44%.
Gross Margin-21.14%
Operating Margin-136.04%
Pretax Margin-154.22%
Net Profit Margin-154.44%
EBITDA Margin-127.38%
EBIT Margin-132.97%
Analyst Forecast
The average price target for American Bio Medica is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―